News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Skin Cancer Drug, Ipilimumab News Boosts Bristol-Myers Squibb Company Shares
June 7, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Bristol-Myers Squibb Co's shares rose more than 5 percent on Monday after news over the weekend that its experimental drug ipilimumab extended survival in patients with deadly skin cancer.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase 2
Phase 3
Bristol Myers Squibb Company
MORE ON THIS TOPIC
IgA nephropathy
Otsuka energizes IgA neuropathy space with new Phase 3 Voyxact data
June 5, 2026
·
2 min read
·
Tristan Manalac
Lymphoma
ADC Therapeutics nosedives on 27 deaths in confirmatory trial for lymphoma drug
June 4, 2026
·
2 min read
·
Tristan Manalac
Insights
Rethinking hair loss treatment
June 4, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Funding
NewLimit snags $435M after seeing age reversal in human liver cells
June 3, 2026
·
2 min read
·
Gabrielle Masson
